AI-generated summary
The authors studied transcranial photobiomodulation, which applies near-infrared light to the brain, in mice and in a 40-subject randomized trial. They report that the light increased non-rapid eye movement sleep and frontal cortex adenosine in mice, and reduced insomnia severity and sleep latency in people. The evidence is preliminary, and the mouse and cell work is translational rather than clinical.
- Participants
- 40
- Who or what was studied
- Mice implanted with fiberoptic cannula and EEG electrodes, in vitro cell cultures, and 40 human subjects with sleep disturbance in a double-blind randomized controlled trial
- Limits stated in the abstract
- The abstract describes the human findings as preliminary and does not report the study's sample characteristics, control details or effect sizes beyond the summary statements.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on nature.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Adenosine triphosphate, Near-infrared, Randomized controlled trial, Insomnia, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.